After the Ace

Chris Sale's 2.06 ERA is the third-lowest by a pitcher 37 or older since 1950. The only names above him are Clemens in 2005 and Verlander in 2022. Both won Cy Youngs. Sale is the certainty. Everything after him is the conversation.

Chase Irle, writing for SportsTalk ATL this week, tried to impose order on the chaos. He ranked the Braves' best options to start a playoff game behind Sale, one through seven: Fuentes, Smith-Shawver, Mahle, Perez, Holmes, Elder, Schwellenbach. The exercise is useful not because the ordering is definitive but because it forces specificity. Names require numbers, and numbers require honesty.

Start with the most provocative choice. Irle put Didier Fuentes at number one — a 21-year-old reliever with five career starts and a 1.84 ERA in 44 innings of relief work. Over his last 16 appearances: 1.06 ERA, 19 strikeouts in 17 innings, three holds and a save. The stuff is undeniable. But converting a reliever to a starter in October is not a statistical argument. It is a leap of faith wearing a lab coat. Fuentes has never faced a major-league lineup three times in the same game. The plural of dominant relief outing is not rotation anchor.

Then there is the other end. Martin Perez carries a 3.24 ERA across 97.1 regular-season innings — the kind of workmanlike consistency that keeps a staff afloat through August. His career postseason numbers tell a different story: 0-1, 9.24 ERA, 12.2 innings spanning three separate Octobers with three separate teams. The sample is small. But 12.2 innings distributed across three postseasons is not noise shaped like a pattern. It is a pattern shaped like noise.

Grant Holmes threw six scoreless innings against the Marlins on Monday — five strikeouts, one walk, his longest outing since June 3. The box score was clean. The splits are not. First time through the order, opposing hitters have posted approximately a .568 OPS against Holmes. Second time through: 1.051. The collapse is not gradual. It is binary. Holmes is two different pitchers separated by eighteen at-bats, and a playoff manager who lifts his starter after five innings is not managing a game. He is managing around a structural flaw.

Tyler Mahle, acquired from the Giants on August 2, brings a 3.79 ERA and 3.63 FIP in seven starts since returning from a hamstring strain. He posted a 2.18 ERA in 16 starts with Texas last year. The post-injury version is encouraging and also seven starts old. He has not yet thrown a pitch in a Braves uniform. AJ Smith-Shawver, Irle's number-two choice, flashed a 97.2-mph fastball in 4.1 innings at Citi Field on July 30 — a 23-year-old arm returning from a UCL procedure. One start does not constitute a case.

Bryce Elder's 3.84 ERA across 119.2 innings makes him the most durable option behind Sale. His barrel rate sits in the 86th percentile, his HR/9 a career-best 0.4 — the contact he allows is soft. But Elder's October resume is one start, Game 3 of the 2023 NLDS, and nobody in the organization has forgotten it. Spencer Schwellenbach has completed four bullpen sessions at the spring training complex and needs three more before facing live hitters. His return — late August, early September, uncertain — remains closer to hope than schedule.

The question 680 The Fan posed this week — whether the Braves carry the worst playoff rotation among NL contenders — is worth answering precisely. The Dodgers can run out Skubal, Yamamoto, Snell, and Ohtani. That is not a comparison; it is a different category. The Phillies offer Sanchez, Wheeler, and Luzardo at the top, but Aaron Nola is pitching to a 5.82 ERA and Philadelphia added no pitching at the deadline. The Cubs acquired Clay Holmes and Gausman. Every contender has a flaw. The Braves' flaw is that behind Sale, they have six question marks and zero proven playoff starters.

But the Braves also have the best bullpen in baseball. Lee, Suarez, and Iglesias have combined for a 1.43 ERA and a .184 opponent batting average across 107.1 innings. The bullpen ERA- of 65 since May 18 is first in the majors. The FIP- of 85 says the performance is structural, not fortunate. The October argument for this 68-45 team is not that the rotation will hold. It is that the games will be short enough to survive it.

Whether you can bullpen your way through four rounds of October is the question this roster was built to answer. The numbers say the rotation behind Sale is the thinnest among NL contenders. The numbers also say the bullpen is the best. Both facts are true. The Braves are betting a 97-win pace and a seven-and-a-half-game lead that the second fact matters more than the first. The evidence is real. The doubt is earned. Baseball does not require you to choose between them.